key: cord-0847631-rye1qjvv authors: Assoun, Sandra; Benderra, Marc‐Antoine; Lotz, Jean‐Pierre; Richard, Sandrine; Gligorov, Joseph title: Severe acute respiratory syndrome Coronavirus 2 infection in cancer population: Are patient‐related symptoms helpful to track a harmful invisible? date: 2020-07-14 journal: Int J Cancer DOI: 10.1002/ijc.33167 sha: 08d5b807932fb4f5a93c85649aca3c965723fe6b doc_id: 847631 cord_uid: rye1qjvv nan hamper the control of COVID-19 outbreak. 2 Reported rates of 40% of hospital-related transmission of SARS-Cov-2 argue that our current preventive approaches testing are inadequate. 3 Therefore, oncologists should adopt alternative device in cancer patients. We report a strategy of systematic detection of COVID-19 symptoms with patientreported questionnaire in cancer patients. We prospectively used a systematic questionnaire covering symptoms of COVID-19 in patients admitted at the Department of Oncology at Tenon Hospital (AP-HP Sorbonne Université) as outpatient or inpatient from March 9 to April 3, 2020 (data cutoff date). All patients underwent temperature measurement at admission. Patients with at least one relevant symptom were appraised by oncologist and underwent nasal swab for SARS-Cov-2 detection by RT-PCR. Clinical data of patients were retrieved from computer files. Patients with thoracic and hematological malignancies were excluded as managed by other departments. We admitted 987 patients in our department and 610 (61.8%) were screened by questionnaire. Sixty-two (10.2%) were hospitalized. Clinical characteristics of patients are summarized in Table 1 Data are available on request due to privacy/ethical restrictions. Written informed consent was obtained from all patients that answered the survey. Marc-Antoine Benderra Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical characteristics of coronavirus disease 2019 in China Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China SARS-CoV-2 transmission in patients with cancer at a tertiary Care Hospital in Wuhan, China